Early Breast Cancer trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Early Breast Cancer trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
  NCT07310420 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: Female · District of Columbia: Washington D.C.
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
  NCT05827081 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · District of Columbia: Washington D.C.